关于公司
Ela Pharma specializes in the development of innovative drugs that address clinical conditions caused by necrosis. It bases the process of development of drugs on a platform for anti-necrosis technology. The prevention and treatment of necrosis is significant to the therapy of numerous pathological conditions and diseases. It bases its technolog on an approach that directly inhibits an intracellular proteolytic enzyme that plays a critical role in the regulation of necrosis pathway.
IL
未知
未知
未验证公司
业务透明度
- 未验证公司信息
- 向他们的客户询问评论
- 没有回复负面评论